Povidone-Iodine
Prostatitis
Hospital de Transplante Doutor Euryclides de Jesus ZerbinimixtureN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Prostatitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE University of Washington | Phase 4 | BB |
DEXAMETHASONE University of Washington | Phase 4 | BB |
Sildenafil University of Washington | Phase 4 | B |
Fosfomycin University Hospital, Rouen | Phase 3 | B |
Gralise Shirley Ryan AbilityLab | Phase 4 | B |
View all 11 →
Same molecule, other indications
Povidone-Iodine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →